Literature DB >> 16905111

Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal.

D Ndiaye1, J P Daily, O Sarr, O Ndir, O Gaye, S Mboup, C Roper, D F Wirth.   

Abstract

We previously reported a high baseline prevalence of mutations in the dhfr and dhps genes of Plasmodium falciparum throughout Senegal. The highest prevalence of the triple dhfr pyrimethamine associated mutations were found in isolates obtained in the western part of the country near the capital city of Dakar. In this study, we sought out to determine the relatedness of dhfr wild type and mutated strains by analyzing three microsatellite regions upstream of the dhfr locus. Twenty-six of the 31 wild type strains had a unique microsatellite pattern. In contrast, of the 17 isolates containing the triple mutation in dhfr, 11 had an identical microsatellite pattern. Diverse geographical isolates in Senegal containing the triple dhfr mutation have arisen from a limited number of ancestral strains. In addition, we demonstrate that these isolates have shared ancestry with the previously reported triple mutation haplotype found in Tanzania, South Africa, and southeast Asia. This common ancestry may have implications for the malaria control strategy for reducing the spread of sulfadoxine-pyrimethamine resistance in Senegal and elsewhere in Africa.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905111      PMCID: PMC2582374          DOI: 10.1016/j.actatropica.2006.07.002

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  15 in total

1.  Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum.

Authors:  Richard Pearce; Allen Malisa; S Patrick Kachur; Karen Barnes; Brian Sharp; Cally Roper
Journal:  Mol Biol Evol       Date:  2005-05-25       Impact factor: 16.240

2.  Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles.

Authors:  Andrea M McCollum; Amanda C Poe; Mary Hamel; Curtis Huber; Zhiyong Zhou; Ya Ping Shi; Peter Ouma; John Vulule; Peter Bloland; Laurence Slutsker; John W Barnwell; Venkatachalam Udhayakumar; Ananias A Escalante
Journal:  J Infect Dis       Date:  2006-06-13       Impact factor: 5.226

Review 3.  Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

Authors:  C H Sibley; J E Hyde; P F Sims; C V Plowe; J G Kublin; E K Mberu; A F Cowman; P A Winstanley; W M Watkins; A M Nzila
Journal:  Trends Parasitol       Date:  2001-12

4.  Complex mutations in a high proportion of microsatellite loci from the protozoan parasite Plasmodium falciparum.

Authors:  T J Anderson; X Z Su; A Roddam; K P Day
Journal:  Mol Ecol       Date:  2000-10       Impact factor: 6.185

Review 5.  Fitness of drug-resistant malaria parasites.

Authors:  David Walliker; Paul Hunt; Hamza Babiker
Journal:  Acta Trop       Date:  2005-04-18       Impact factor: 3.112

6.  Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.

Authors:  G Snounou; X Zhu; N Siripoon; W Jarra; S Thaithong; K N Brown; S Viriyakosol
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Jul-Aug       Impact factor: 2.184

7.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal.

Authors:  D Ndiaye; J P Daily; O Sarr; O Ndir; O Gaye; S Mboup; D F Wirth
Journal:  Trop Med Int Health       Date:  2005-11       Impact factor: 2.622

8.  Selection strength and hitchhiking around two anti-malarial resistance genes.

Authors:  Denae Nash; Shalini Nair; Mayfong Mayxay; Paul N Newton; Jean-Paul Guthmann; François Nosten; Tim J C Anderson
Journal:  Proc Biol Sci       Date:  2005-06-07       Impact factor: 5.349

9.  Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America.

Authors:  Joseph F Cortese; Alejandro Caraballo; Carmen E Contreras; Christopher V Plowe
Journal:  J Infect Dis       Date:  2002-09-09       Impact factor: 5.226

10.  [Comparison of the transmission of malaria in 2 epidemiological patterns in Senegal: the Sahel border and the Sudan-type savanna].

Authors:  O Faye; O Gaye; D Fontenille; N Sy; L Konate; G Hebrard; J P Herve; J Trouillet; S Diallo; J Mouchet
Journal:  Dakar Med       Date:  1995
View more
  18 in total

1.  Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.

Authors:  Md Tauqeer Alam; Dziedzom K de Souza; Sumiti Vinayak; Sean M Griffing; Amanda C Poe; Nancy O Duah; Anita Ghansah; Kwame Asamoa; Laurence Slutsker; Michael D Wilson; John W Barnwell; Venkatachalam Udhayakumar; Kwadwo A Koram
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal.

Authors:  Babacar Faye; Magatte Ndiaye; Jean Louis Ndiaye; Abiola Annie; Roger Clement Tine; Aminata Collé Lo; Mohamed Ndiaye; Doudou Sow; Alexandra De Sousa; Oumar Gaye
Journal:  Parasitol Res       Date:  2011-01-05       Impact factor: 2.289

3.  Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.

Authors:  Mónica Guerra; Rita Neres; Patrícia Salgueiro; Cristina Mendes; Nicolas Ndong-Mabale; Pedro Berzosa; Bruno de Sousa; Ana Paula Arez
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

4.  Molecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania.

Authors:  A Malisa; R Pearce; S Abdullah; B Mutayoba; H Mshinda; P Kachur; P Bloland; C Roper
Journal:  Afr Health Sci       Date:  2011-06       Impact factor: 0.927

5.  Origin and evolution of sulfadoxine resistant Plasmodium falciparum.

Authors:  Sumiti Vinayak; Md Tauqeer Alam; Tonya Mixson-Hayden; Andrea M McCollum; Rithy Sem; Naman K Shah; Pharath Lim; Sinuon Muth; William O Rogers; Thierry Fandeur; John W Barnwell; Ananias A Escalante; Chansuda Wongsrichanalai; Frederick Ariey; Steven R Meshnick; Venkatachalam Udhayakumar
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

6.  Tracing the origins and signatures of selection of antifolate resistance in island populations of Plasmodium falciparum.

Authors:  Patrícia Salgueiro; José L Vicente; Conceição Ferreira; Vânia Teófilo; André Galvão; Virgílio E do Rosário; Pedro Cravo; João Pinto
Journal:  BMC Infect Dis       Date:  2010-06-09       Impact factor: 3.090

7.  Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.

Authors:  Laura K Certain; Marnie Briceño; Steven M Kiara; Alexis M Nzila; William M Watkins; Carol Hopkins Sibley
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

8.  Transmission and cross-mating of high-level resistance Plasmodium falciparum dihydrofolate reductase haplotypes in The Gambia.

Authors:  Amani Kheir; Davis Nwakanma; Aisha Al-Gazali; Yagut Akbarova; Salma Al-Saai; Göte Swedberg; Hamza A Babiker
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

9.  Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.

Authors:  Alassane Dicko; Issaka Sagara; Abdoulaye A Djimdé; Sidy O Touré; Mariam Traore; Souleymane Dama; Abdoulbaki I Diallo; Amadou Barry; Mohamed Dicko; Oumar M Coulibaly; Christophe Rogier; Alexandra de Sousa; Ogobara K Doumbo
Journal:  Malar J       Date:  2010-01-10       Impact factor: 2.979

10.  Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.

Authors:  Cristina Mendes; Patrícia Salgueiro; Vicenta Gonzalez; Pedro Berzosa; Agustin Benito; Virgílio E do Rosário; Bruno de Sousa; Jorge Cano; Ana Paula Arez
Journal:  Malar J       Date:  2013-03-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.